Stock listing

MAZE Stock Price, News, Filings & Events — Maze Therapeutics, Inc.

Selected listing: MAZE · BOATS · USD · US

This page tracks Maze Therapeutics, Inc.'s MAZE:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following MAZE:BOATS. MAZE:BOATS is the stock-level entry point for investors researching Maze Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Maze Therapeutics, Inc. is a public company listed under the ticker MAZE, operating in the American market. The company has a market capitalization of approximately $1.53 billion. Maze Therapeutics focuses on developing innovative therapies to address genetic diseases.

MAZE:BOATSUSDUSUpdated August 28, 2026
Maze Therapeutics, Inc. logo
Ticker
MAZE:BOATS
Asset type
Stock
Market cap
$1.52B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
BOATS
Currency
USD

Maze Therapeutics, Inc. MAZE:BOATS stock context

This page tracks Maze Therapeutics, Inc.'s MAZE:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following MAZE:BOATS. MAZE:BOATS is the stock-level entry point for investors researching Maze Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Maze Therapeutics, Inc. is a public company listed under the ticker MAZE, operating in the American market. The company has a market capitalization of approximately $1.53 billion. Maze Therapeutics focuses on developing innovative therapies to address genetic diseases.

Latest news from Maze Therapeutics, Inc.

All Maze Therapeutics, Inc. news →

Maze Therapeutics, Inc. earnings calls

Research Maze Therapeutics, Inc.

Alternate listings